Gerardo Hernandez
Vermogen: 3 M $ op 31-08-2026
Vermogen: 3 M $ op 31-08-2026
Mr. Gerardo Hernandez was previously employed as a Chief Financial Officer & Treasurer by TransMedics Group, Inc. and a VP-Finance & Head-Financial Planning & Analysis by Alnylam Pharmaceuticals, Inc. He received his undergraduate degree from the University of Wisconsin La Crosse and an MBA from Escola de Administração de Empresas de São Paulo.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 10-07-2026 | 31.935 ( 0,09% ) | 3 M $ | 31-08-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
| TRANSMEDICS GROUP, INC. | Financieel Directeur/CFO | 21-09-2026 |
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-09-2024 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Escola de Administração de Empresas de São Paulo
Escola de Administração de Empresas de São Paulo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin La Crosse
University of Wisconsin La Crosse Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TransMedics Group, Inc.
TransMedics Group, Inc. Medical SpecialtiesHealth Technology Manufactures portable electromechanical medical devices for organ transplantation of end-stage organ failure patients | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau